Financial Year |
March 31 2023 |
Monetary Funds |
52,402,528.78 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
221,386,476.31 |
Advances to Suppliers |
9,713,022.15 |
Other Receivables |
45,397,645.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
84,214,518.86 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,319,784.11 |
Total Current Assets |
415,908,039.99 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
67,041,518.43 |
Under-construction Projects |
382,525.54 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
28,384,821.28 |
R&D expenses |
-- |
Goodwill |
50,588,607.19 |
Long-Term Deferred and Prepaid Expenses |
12,281,296.61 |
Deferred Income Tax Assets |
685,712.43 |
Other Non-Current Assets |
402,429.83 |
Sub-Total of Non-Current Assets |
170,852,083.21 |
Total Assets |
586,760,123.20 |
Short-Term Loans |
16,500,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
55,769,118.88 |
Accounts Payable |
165,952,201.50 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
14,997,091.42 |
Taxes Payable |
8,865,402.06 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
147,535,478.48 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,444,020.05 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
419,114,657.39 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
2,195,363.25 |
Deferred Income Tax Liabilities |
987,577.92 |
Other Non-Current Liabilities |
2,115,835.62 |
Sub-Total of Non-Current Liabilities |
28,015,367.93 |
Total Liabilities |
447,130,025.32 |
Paid-In Capital(Or Share Stock) |
511,697,213.00 |
Capital Surplus |
467,828,911.07 |
Surplus Reserve |
97,172,585.40 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-946,263,897.65 |
Minority Stockholder's Interest |
2,983,308.54 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
136,646,789.34 |
Owner's Equity(Stockholder's Equity) |
139,630,097.88 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
586,760,123.20 |